Start a Diagnostic-Accessibility Market-Access Advisory

1. 1

   Turn accessibility into a commercial strategy

   Startups like an Alzheimer's blood test or a handheld stroke sensor position themselves as lower-cost, accessible alternatives to MRI and CT, but a strong positioning is not a market-access plan. Your role is to convert that accessibility story into concrete strategy: which payers to pursue, which health systems and settings to target, and how to price. Being the advisor who operationalizes the accessibility angle is the wedge, so build a repeatable framework for it.

2. 2

   Master diagnostics reimbursement and coding

   A diagnostic only scales if it gets paid for, so you must understand reimbursement pathways, coding, and how payers evaluate a cheaper alternative to an established imaging test. Sometimes accessibility strengthens the payer case (lower cost, earlier detection) and sometimes it complicates it (new test, no code yet). Fluency in these dynamics is your core value, so ground your advice in real reimbursement mechanics, not just the cost-savings narrative.

3. 3

   Target the settings imaging cannot reach

   The accessibility advantage is strongest exactly where fixed imaging is absent: rural and community hospitals, emergency medical services, primary care, and low-resource settings. Help clients identify and prioritize these settings, size them, and build a go-to-market that reaches them. This is where an accessible diagnostic wins that an incumbent scanner cannot, so the strategy should lean into those settings rather than competing head-on with hospital imaging.

4. 4

   Build the value dossier for buyers

   Health systems and payers buy evidence, so help clients assemble the clinical and economic value dossier that shows the accessible test delivers comparable clinical value at lower cost and reaches more patients. Package the case for each buyer type. A compelling, evidence-based value story is what turns an accessibility claim into adoption, and building it is a concrete, fee-worthy deliverable.

5. 5

   Position and sell the advisory across diagnostics

   The accessibility pattern recurs across diagnostics well beyond neurology, so your addressable market is any startup whose pitch is a cheaper, more accessible alternative to expensive testing. Build referral relationships with diagnostics investors and founders and publish on accessible-diagnostics market access. This card is distinct from the FDA regulatory and reimbursement-strategy cards: it focuses specifically on the accessibility positioning and the underserved-setting go-to-market.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Diagnostics market-access, reimbursement, and commercialization professionals

Not for: This is not for someone without real diagnostics market-access and reimbursement experience. It is a low-capital advisory, and it overlaps with but is distinct from the reimbursement-strategy consultancy (which centers on razor-and-blade device margins) and FDA regulatory consulting.